{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:10:29Z","timestamp":1789978229287,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ajog.2017.04.029","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:47:16Z","timestamp":1493167636000},"page":"461.e1-461.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Assessing the potential impact of extending antenatal steroids to the late preterm period"],"prefix":"10.1016","volume":"217","author":[{"given":"Vivienne","family":"Souter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie G.","family":"Katon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.04.029_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"for the NICHD Maternal-Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.029_bib2","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/AOG.0000000000001715","article-title":"Antenatal corticosteroid therapy for fetal maturation. Committee opinion no. 677","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.029_bib3","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.ajog.2016.03.013","article-title":"Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery","volume":"215","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.029_bib4","first-page":"1","article-title":"Births: final data for 2013","volume":"64","author":"Martin","year":"2015","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2017.04.029_bib5","series-title":"Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health: clinical practice guidelines","year":"2015"},{"key":"10.1016\/j.ajog.2017.04.029_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0000000000000655","article-title":"Use of antenatal corticosteroid prophylaxis","volume":"125","author":"Goldenberg","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.029_bib7","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.04.029_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/1471-0528.13853","article-title":"Antenatal corticosteroids: a time for more careful scrutiny of the indications?","volume":"123","author":"Vidaeff","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.04.029_bib9","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/1471-0528.13929","article-title":"Antenatal corticosteroids in perspective: rationalizing current practice","volume":"123","author":"Ridout","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.04.029_bib10","first-page":"486","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"375","author":"Redlich","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.029_bib11","first-page":"486","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"375","author":"Smith","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.029_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajog.2016.06.023","article-title":"Antenatal corticosteroids beyond 34 weeks gestation: what do we do now?","volume":"215","author":"Kamath-Rayne","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.04.029_bib13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1542\/peds.2014-2177","article-title":"Regional variation in antenatal corticosteroid use: a network-level quality improvement study","volume":"135","author":"Profit","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2017.04.029_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal betamethasone and incidence of neonatal respiratory distress after elective cesarean section: pragmatic randomized trial","volume":"331","author":"Stutchfield","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2017.04.029_bib15","series-title":"NICE clinical guideline 63: diabetes in pregnancy. Management of diabetes and its complications from pre-conception to the postnatal period","year":"2008"},{"key":"10.1016\/j.ajog.2017.04.029_bib16","series-title":"NICE clinical guideline (NG25): preterm labor and birth","year":"2015"},{"key":"10.1016\/j.ajog.2017.04.029_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.38576.494363.E0","article-title":"Antenatal exposure to betamethasone: psychological functioning and health-related quality of life 31 years after inclusion in randomized controlled trial","volume":"331","author":"Dalziel","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2017.04.029_bib18","doi-asserted-by":"crossref","first-page":"F195","DOI":"10.1136\/archdischild-2012-303157","article-title":"Behavioral, educational and respiratory outcomes of antenatal betamethasone for term cesarean section (ASTECS trial)","volume":"98","author":"Stutchfield","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2017.04.029_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2393-14-272","article-title":"Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5)","volume":"14","author":"Asztalos","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2017.04.029_bib20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal glycemia and neurodevelopmental outcomes at 2 years","volume":"373","author":"McKinlay","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.04.029_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapediatrics.2015.1631","article-title":"Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study","volume":"169","author":"Kaiser","year":"2015","journal-title":"JAMA Pediatr"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817305586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817305586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:16:33Z","timestamp":1757589393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817305586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0002937817305586"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.04.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the potential impact of extending antenatal steroids to the late preterm period","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}